Technology Stocks & Market Talk With Don Wolanchuk Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk

SOXL 55.38

-1.2%

Jan 14 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: seminole who wrote (114084)	6/4/2018 1:20:43 PM
From: seminole	Read Replies (1) of 207817

OT; Merck news out of the big drug/cancer conference in Chicago. Merck's shares up 2 pct at $61.79 after data from 2 trials showed Keytruda, which competes with Bristol-Myers' Opdivo, improved survival in certain lung cancer patients Merck was a Dow 'Dog' stock last year......

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next